Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 165
Selected: 0
NCT IDTitle
NCT01273922Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida
NCT01980979Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension
NCT02603068Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
NCT04084678Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects
NCT05340426Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney Disease
NCT02847260Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)
NCT01260454The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain
NCT07261241NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
NCT01268553Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
NCT00911248PTC299 for Treatment of Neurofibromatosis Type 2
NCT00692354Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours
NCT04850105A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT06335407Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
NCT07116681Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension
NCT03794583Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT03950739Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso
NCT01560637An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
NCT02370095Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
NCT02633293An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
NCT01934582A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
NCT03496623A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
NCT04677829Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
NCT02360345Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly
NCT00848939Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis
NCT01996254Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System
NCT00439946Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
NCT03037580Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
NCT07037836Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
NCT05776225Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
NCT03055221TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)
NCT03016468Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH
NCT02149095Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of TransCon PEG Treprostinil in Healthy Male Volunteers
NCT04827056Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
NCT01353027Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
NCT00060996Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
NCT01588405Remodulin® to Oral Treprostinil Transition
NCT00760916FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT03683186A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT04708782Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT01007890Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
NCT02583789Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
NCT01043627Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
NCT03043651Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF
NCT06425796Adiposity and Iron Requirements in Pregnancy
NCT01165476Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities
NCT00159250Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
NCT00373360Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin
NCT01494896Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
NCT02261883Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
NCT01795950Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)